Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6537
    +0.0014 (+0.22%)
     
  • OIL

    83.75
    +0.18 (+0.22%)
     
  • GOLD

    2,351.30
    +8.80 (+0.38%)
     
  • Bitcoin AUD

    97,833.70
    -991.17 (-1.00%)
     
  • CMC Crypto 200

    1,333.77
    -62.77 (-4.49%)
     
  • AUD/EUR

    0.6107
    +0.0033 (+0.55%)
     
  • AUD/NZD

    1.0993
    +0.0036 (+0.32%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,739.48
    +308.97 (+1.77%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,281.33
    +195.53 (+0.51%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Why Beyond Meat Stock Withered on Wednesday

Why Beyond Meat Stock Withered on Wednesday

Beyond Meat (NASDAQ: BYND), the bellwether alternative-protein stock, lost a little weight on the stock market Wednesday. The first note was a reiteration, with Piper Sandler prognosticator Michael Lavery leaving unchanged his neutral recommendation and $64 price target on Beyond Meat stock. In his latest note on the company, Lavery waxed enthusiastic about the prospects of the McPlant, the Beyond Meat-developed sandwich being tested as a menu item by McDonald's. Pointing out that the McPlant will be rolled out in a new phase to around 600 McDonald's restaurants in California and Texas next month, he wrote that this "suggests a full U.S. launch to nearly 14,000 restaurants is likely coming later than the end of 1Q."